METASTATIC COLORECTAL ADENOCARCINOMA
Clinical trials for METASTATIC COLORECTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop transplant trial aims to jumpstart cancer treatment
Disease control OngoingThis study is testing if a fecal microbiota transplant (FMT) can help immunotherapy drugs work for people with advanced colorectal cancer who previously did not respond to them. The FMT uses processed stool from patients who did respond to the treatment, with the goal of changing…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Major trial pits Triple-Threat combo against single drug for Tough-to-Treat colon cancer
Disease control OngoingThis large, late-stage trial is comparing two treatment strategies for advanced colorectal cancer that has a specific genetic feature (dMMR/MSI-H). One group receives a single immunotherapy drug (atezolizumab), while another gets that same drug combined with standard chemotherapy…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo tested for Tough-to-Treat colorectal cancer
Disease control OngoingThis study is testing whether two drugs, panitumumab and trametinib, can help control advanced colorectal cancer that has stopped responding to a previous, similar type of treatment. It involves 59 patients whose cancer has spread and who have specific genetic markers in their bl…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Custom cancer vaccine tailored from Patient's own tumor tested in new trial
Disease control OngoingThis early-stage study is testing a personalized vaccine made from a patient's own tumor cells and blood. It aims to see if creating and giving this custom vaccine is safe and possible for people with advanced pancreatic or colorectal cancer that has spread. The vaccine is design…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
Four-Pronged attack on Tough-to-Treat colon cancer
Disease control OngoingThis study is testing a new combination of four drugs for people with a common type of advanced colorectal cancer that has spread. The goal is to find the safest and most effective dose and see if this four-drug approach can help control the cancer. It combines standard chemother…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New hope for Tough-to-Treat colon cancer: trial tests Triple-Threat therapy
Disease control OngoingThis trial is testing a new combination of three drugs for people with a common type of advanced colon cancer that has spread and is no longer responding to standard chemotherapy. The goal is to see if two immunotherapy drugs that help the immune system attack cancer, combined wi…
Matched conditions: METASTATIC COLORECTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC